Stroke Trial, Recruiting NCT06113380 Sponsor: National Taiwan University Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06113380
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had their first-ever stroke between 2 weeks and 2 years ago, which has left one side of the body weakened or paralysed.
  • People who are able to understand and follow simple instructions.
  • People who can sit upright and maintain their balance while seated.
  • People whose arm and leg movement recovery falls within a mid-range on a standard stroke recovery scale called the Brunnstrom Scale (levels 2 through 5) (confirm with trial site).
  • People who have had either a stroke caused by a blood clot (ischemic) or one caused by bleeding in the brain (hemorrhagic).

Who may not be able to join:

  • People who are not yet fully conscious or alert.
  • People who have a psychiatric (mental health) disorder, or who have developed mental health or behavioural changes as a result of their stroke.
  • People whose thinking or behaviour difficulties would prevent them from understanding or completing the trial tasks.
  • People with severe difficulty speaking or understanding language (aphasia) that would prevent them from following the researchers' instructions.
  • People with serious heart or lung conditions, or any other significant internal medical condition that could put their safety at risk.
  • People who require complete bed rest due to a serious illness.
  • People who have a shoulder joint condition that would prevent them from doing exercise therapy.
  • People with severe osteoporosis where physical activity raises concerns about the risk of fractures.
  • People who have an irregular heartbeat (arrhythmia) and have a pacemaker implanted.
  • People with severe seizures that have not been able to be controlled through medication, physical therapy, botulinum toxin injections, or nerve block procedures.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-2312-3456 ext 67048

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 October 2023
Est. completion
22 December 2025

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Fugl-Meyer Assessment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov